ArticleRisk analysis : an official publication of the Society for Risk Analysis2026
Risk Assessment and Management of Brucella canis Introduction via Commercial Dog Imports Into France.
Article in Risk analysis : an official publication of the Society for Risk Analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Canine brucellosis, caused by Brucella canis, is a likely underdiagnosed zoonotic disease that leads to reproductive failure in dogs and economic losses for kennels. Since 2020, cases in mainland France have been on the rise, with most attributed to the importation of dogs from Eastern Europe. However, the risk of introducing B. canis into mainland France through commercial dog imports from worldwide sources remains poorly characterized. To address this gap, a quantitative risk assessment was conducted using a stochastic scenario tree model incorporating the region of origin of the imported dogs. In addition, impact of management measures on the annual number of B. canis-infected dogs imported into France was evaluated. The results showed that the commercial dog imports represent a substantial risk for introducing B. canis into mainland France, with a median annual number of infected dogs imported estimated at 41.60 (95% PI: 5.12-8784.00). This risk was particularly high for imports originating from the USA, Eastern Europe, North Africa, and Latin America. The evaluation of management measures through simulations showed that the introduction of mandatory pre-import testing for B. canis, with 80% compliance or full enforcement-could significantly reduce the associated risk. These measures led to a reduction in the annual number of infected dogs imported into mainland France by a factor of 4 to 1000 compared to the baseline model. These findings highlight the need for implementing targeted management measures to prevent the introduction of B. canis into France.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.